Abstract

Adipocyte fatty acid binding protein (A-FABP) is a novel adipokine that contributes to the development of cardiovascular disease because of pro-inflammatory properties. Our study aims to evaluate the correlation between serum A-FABP and aortic stiffness in diabetic kidney disease (DKD). Fasting blood samples were obtained from 96 type 2 diabetes mellitus patients with DKD. DKD is identified clinically by persistently high urinary albumin-to-creatinine ratio (UACR) ≥ 30 mg/g and/or sustained reduction in estimated glomerular filtration rate (eGFR) below 60 ml/min per 1.73 m2. Carotid-femoral pulse wave velocity (cfPWV) was measured by using pressure applanation tonometry. cfPWV values of > 10 m/s represented the high aortic stiffness group according to the ESH-ESC 2013. Serum A-FABP levels were determined using a commercial enzyme immunoassay. 53 participants (55.2%) fell under the high aortic stiffness group. This group, compared to the control group, showed higher prevalence of male (P = 0.015), older age (P = 0.025), higher systolic blood pressure (P = 0.001), diastolic blood pressure (P = 0.037), urine albumin-to-creatinine ratio (P = 0.007), serum total cholesterol (P = 0.030), low-density lipoprotein cholesterol (P = 0.043), and A-FABP (P < 0.001). After adjusting for factors significantly associated with aortic stiffness using multivariable logistic regression analysis, serum A-FABP [odds ratio = 1.487 (1.210–1.829), P < 0.001] was found to be an independent predictor of aortic stiffness in DKD patients. Multivariable forward stepwise linear regression analysis also showed that serum logarithmically transformed A-FABP level (log-A-FABP, β = 0.587, adjusted R2 change: 0.426, P <0.001) was positively associated with cfPWV values in DKD patients. In this study, serum A-FABP level is found to be positively correlated with cfPWV values and is identified as an independent predictor of aortic stiffness in DKD patients after adjusting for significant confounders.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call